These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29692583)

  • 1. Effect of introduction of single-donor apheresis platelets in dengue management: A comparative analysis of two consecutive dengue epidemics.
    Kansay S; Singh H
    J Lab Physicians; 2018; 10(2):173-178. PubMed ID: 29692583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of platelet transfusion in the management of dengue patients in a tertiary care hospital.
    Makroo RN; Raina V; Kumar P; Kanth RK
    Asian J Transfus Sci; 2007 Jan; 1(1):4-7. PubMed ID: 21938225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of platelet transfusion in children with bleeding in dengue fever.
    Pothapregada S; Kamalakannan B; Thulasingam M
    J Vector Borne Dis; 2015 Dec; 52(4):304-8. PubMed ID: 26714510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of efficacy of low and high dose prophylactic platelet transfusion therapy in thrombocytopenic haemato-oncology patients.
    Dhiman Y; Hans R; Sharma RR; Malhotra P; Marwaha N
    Transfus Apher Sci; 2020 Feb; 59(1):102610. PubMed ID: 31345687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and quality evaluation of apheresis vs random-donor platelet concentrates stored for 7 days.
    Hussein E
    Transfus Med; 2015 Feb; 25(1):20-6. PubMed ID: 25808050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfurling the rationale use of platelet transfusion in dengue Fever.
    Pallavi P; Ganesh CK; Jayashree K; Manjunath GV
    Indian J Hematol Blood Transfus; 2011 Jun; 27(2):70-4. PubMed ID: 22654295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components.
    Xiao W; Tormey CA; Capetillo A; Maitta RW
    Vox Sang; 2013 Nov; 105(4):334-40. PubMed ID: 23802769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of cross-match compatible platelets in multi transfused haemato-oncology patients refractory to platelet transfusion.
    Chavan A; Sharma RR; Saikia B; Malhotra P; Prakash S; Hans R; Marwaha N
    Transfus Apher Sci; 2019 Dec; 58(6):102657. PubMed ID: 31706911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective Review of Platelet Transfusion Practices during 2013 Dengue Epidemic of Delhi, India.
    Chaurasia R; Zaman S; Chatterjee K; Das B
    Transfus Med Hemother; 2015 Jul; 42(4):227-31. PubMed ID: 26557814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Era of blood component therapy: time for mandatory pre-donation platelet count for maximizing donor safety and optimizing quality of platelets.
    Das SS; Zaman RU; Biswas D
    Transfus Apher Sci; 2013 Dec; 49(3):640-3. PubMed ID: 23928130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Harm of Prophylactic Platelet Transfusion in Adult Dengue Patients.
    Lee TH; Wong JG; Leo YS; Thein TL; Ng EL; Lee LK; Lye DC
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004576. PubMed ID: 27015272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single donor platelets: can we afford to use them? Can we afford not to use them?
    Zeger G; Williams CT; Shulman IA
    Transfus Sci; 1997 Dec; 18(4):585-8. PubMed ID: 10178683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet audit: Assessment and utilization of this precious resource from a tertiary care hospital.
    Saluja K; Thakral B; Marwaha N; Sharma RR
    Asian J Transfus Sci; 2007 Jan; 1(1):8-11. PubMed ID: 21938226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of platelet transfusion in dengue Fever: a randomized controlled trial.
    Khan Assir MZ; Kamran U; Ahmad HI; Bashir S; Mansoor H; Anees SB; Akram J
    Transfus Med Hemother; 2013 Oct; 40(5):362-8. PubMed ID: 24273491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The north Indian dengue outbreak 2006: a retrospective analysis of intensive care unit admissions in a tertiary care hospital.
    Chandralekha ; Gupta P; Trikha A
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):143-7. PubMed ID: 18093628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Pooled Platelet Transfusion in Concordant and Discordant Groups among Dengue Patients.
    Bhat A; Chowdappa V; Masamatti SS
    J Clin Diagn Res; 2016 Jul; 10(7):EC21-4. PubMed ID: 27630853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febrile reactions after platelet transfusion: the effect of single versus multiple donors.
    Chambers LA; Kruskall MS; Pacini DG; Donovan LM
    Transfusion; 1990; 30(3):219-21. PubMed ID: 1967118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.